Biotechnology

Invivoscribe Announces FDA Approval of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with FLT3-ITD Positive AML for Treatment with VANFLYTA

SAN DIEGO, July 21, 2023 /PRNewswire/ -- Invivoscribe is excited to announce that the LeukoStrat® CDx FLT3 Mutation Assay has been approved by the U.S. Food and Drug Administration (FDA) to aid in the selection of patients with newly diagnosedFLT3-ITD positive acute myeloid leukemia (AML) who may...

2023-07-21 18:00 2878

GC Biopharma's "GC FLU" obtains vaccine approval in Egypt: First-ever approval of the company's quadrivalent flu vaccine on the African continent

* Striving to further expand its territory to Africa and the Middle East from Southeast Asia and Latin America * "Will create synergy between international procurement market and private markets of individual countries so as to boost sales and profitability" YONGIN, South Korea, July 21, 2023...

2023-07-21 16:47 2013

US FDA Grants Orphan Drug Designation of SN Bioscience's Nano Anti-Cancer Drug 'SNB-101' for Small Cell Lung Cancer

SEONGNAM, South Korea, July 20, 2023 /PRNewswire/ -- SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced onJuly 19 that the US FDA had granted an orphan drug designation for small cell lung cancer for SNB-101 (API: SN-38), a new polymer nanoparticle drug under development. SNB-101 is the world...

2023-07-21 08:15 1919

Lynk Pharmaceuticals Announces First Atopic Dermatitis Patient Dosed with LNK01004 in Phase Ib Clinical Study

HANGZHOU, China, July 21, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that it has dosed the first patient with atopic dermatitis in a Phase Ib clinical trial of its innovative drug LNK0100...

2023-07-21 08:00 2938

Angel Yeast Highlights Sustainable Protein and Natural Taste Solutions at IFT FIRST 2023

CHICAGO, July 20, 2023 /PRNewswire/ -- Angel Yeast (SHA:600298), a premier global yeast company, showcased its sustainable yeast protein and compound seasoning solutions at the annual expo of the Institute of Food Technologists ("IFT FIRST 2023"), inChicago, that took...

2023-07-20 20:00 2427

Viva Biotech's Portfolio Company Riparian Pharmaceuticals Announces Exclusive License Agreement and Research Agreement with Pfizer for Novel Cardiovascular Programs

WATERTOWN, Mass., July 20, 2023 /PRNewswire/ -- Riparian Pharmaceuticals, a Viva Biotech portfolio company, is a biotechnology company focused on discovering novel therapeutics for cardiovascular diseases. Riparian today announced it has entered into an exclusive license agreement and research a...

2023-07-20 19:15 2409

PolyU awarded RGC Strategic Topics Grant to address societal needs in mental healthcare

HONG KONG, July 20, 2023 /PRNewswire/ -- The Hong Kong Polytechnic University (PolyU) has received funding support from the Strategic Topics Grant (STG) 2023/24 of the Research Grants Council (RGC) for a health technology project aimed at promoting a new paradigm shift with creation of an integra...

2023-07-20 19:07 2175

BioCity announces the first patient dosed with its first-in-class CDH3-targeting ADC BC3195 in a Phase 1 Trial

WUXI, China, July 19, 2023 /PRNewswire/ -- BioCity Biopharma, a clinical-stage biopharmaceutical company committed to developing novel and highly differentiated, modality-independent therapeutics for cancer and autoimmune disorders, today announced the dosing of the first patient in a Phase 1a/1b...

2023-07-20 10:41 1973

Biotheus Announces Strategic Research Collaboration and Worldwide License Agreement with BioNTech

ZHUHAI, China, July 19, 2023 /PRNewswire/ -- Biotheus Inc. ("Biotheus"), a clinical-stage biotech company dedicated to the discovery and development of biologics for oncology and inflammatory diseases, announced today that it has entered into a strategic research collaboration, option and worldwi...

2023-07-20 09:01 1958

Origin Agritech Secures RMB 2 Million Grant for Building Germplasm Bank in Xinjiang

BEIJING, July 19, 2023 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology company, announced today that it has been awarded a grant ofRMB 2 million (approximately $280,000 USD) from the Xinjiang government. The grant aims to support Origin's...

2023-07-19 23:54 5366

Kintor Pharma Announces Completion of First Patient Enrollment in Long-term Safety Phase III Trial of KX-826 for Treatment of AGA

SUZHOU, China, July 19, 2023 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced that the company has initiated the long-term safety trial (the "Long-term ...

2023-07-19 21:03 2133

Significantly Reduce Manufacturing Cost and Increased Local Production: SCG Cell Therapy Opens State-of-the-art Cell Therapy Manufacturing Facility and R&D Centre in Singapore

* SCG Cell Therapy celebrates the opening of its new Cell Therapy Manufacturing Facility and R&D Centre, launching a new first-of-its-kind automatic cell therapy manufacturing system in Singapore, pioneeringSingapore's Manufacturing 2030 Vision.   * Facility will substantially increase local ...

2023-07-19 19:20 3488

First Patient Dosed in STARSTRUCK Study of TLX250 Targeted Radiation Therapy in Combination with Merck Investigational DNA-PK Inhibitor, Peposertib

MELBOURNE, Australia, July 19, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a Phase I study of the Company's investigational targeted radiation therapy, TLX250, in combination with a Merck KGaA, Darmstad...

2023-07-19 05:00 2285

Mabwell Announces the NMPA Approval of Novel Trop-2 ADC (9MW2921) for IND

SHANGHAI, July 18, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its clinical trial application of 9MW2921 for advanced solid tumor was approved by the National Medical Products Administration (NMPA). 9MW2921 is dev...

2023-07-19 00:00 2762

Duoning Biotech Acquires PreFluid to Strengthen Fluid Management Solutions

* PreFluid is a leader in integrated fluid solutions * PreFluid's peristaltic pumps are widely used in medical, pharmaceutical, chemical and environmental industries worldwide SHANGHAI, July 18, 2023 /PRNewswire/ -- Duoning Biotechnology Co., Ltd. ("Duoning Biotech") has used Shanghai Duoning...

2023-07-18 20:00 2336

Samsung Biologics releases 2023 ESG Report, reaffirming its commitment to net-zero progress and corporate social responsibility

INCHEON, South Korea, July 18, 2023 /PRNewswire/ -- Samsung Biologics (KRX: 207940), a global contract development and manufacturing organization (CDMO), today released its 2023 Environmental, Social and Governance (ESG) Report. The annual report outlines the company's progress toward its sustain...

2023-07-18 19:00 1859

2nd ZAODX World Conference on Early Detection of Cancer to Take Place in September 2023

GUANGZHOU, China, July 18, 2023 /PRNewswire/ -- The 2nd ZAODX World Conference on Early Detection of Cancer(EDOC-2)will take place on-site at the Huangpu International Conference Center,Guangzhou, China, and online in a virtual format from 15 to17 September, 2023. The conference aims to promote ...

2023-07-18 17:59 1388

Viva Biotech's Portfolio Company DTx Pharma Reached the Acquisition Agreement with Novartis

* DTx Pharma's Fatty Acid Ligand Conjugated Oligonucleotide (FALCON™) platform facilitates extra-hepatic delivery of siRNA therapeutics * Acquisition includes DTx-1252 with the potential to deliver a transformative medicine to Charcot-Marie-Tooth Disease Type 1A (CMT1A) patients * Acquisitio...

2023-07-18 15:00 5014

Join Taipei City's Thriving Health Industry: Registration for "Win A Greater Health" Pitch Contest Starts Now!

TAIPEI, July 18, 2023 /PRNewswire/ -- The Taipei City Government's Department of Economic Development is taking proactive steps to attract international startups and foster collaboration with local businesses through its "Talent Exchange Program". In line with this initiative, they have establish...

2023-07-18 11:35 1962

TradeWinds Partners with TMBIA to Showcase Taiwan Pavilion at VIETNAM MEDI-PHARM EXPO

TAIPEI, July 18, 2023 /PRNewswire/ -- TradeWinds has partnered with the TMBIA to organize a Taiwan Pavilion with the aim of expanding the medical device market inVietnam. They will be participating VIETNAM MEDI-PHARM EXPO at Saigon Exhibition and Convention Center (SECC) fromAugust 3 to 5. Stand...

2023-07-18 09:00 2402
1 ... 91929394959697 ... 307

Week's Top Stories